Mitchell Sinkler & Starr PA Buys New Stake in HCA Healthcare, Inc. (NYSE:HCA)

Mitchell Sinkler & Starr PA bought a new stake in shares of HCA Healthcare, Inc. (NYSE:HCA) in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm bought 660 shares of the company’s stock, valued at approximately $212,000.

Several other institutional investors also recently bought and sold shares of HCA. Principal Securities Inc. bought a new stake in shares of HCA Healthcare in the 4th quarter worth about $303,000. Envestnet Portfolio Solutions Inc. increased its holdings in shares of HCA Healthcare by 354.3% in the 4th quarter. Envestnet Portfolio Solutions Inc. now owns 13,274 shares of the company’s stock worth $3,593,000 after buying an additional 10,352 shares during the last quarter. Avantax Advisory Services Inc. increased its holdings in shares of HCA Healthcare by 8.5% in the 4th quarter. Avantax Advisory Services Inc. now owns 4,669 shares of the company’s stock worth $1,264,000 after buying an additional 364 shares during the last quarter. Quotient Wealth Partners LLC bought a new stake in shares of HCA Healthcare in the 4th quarter worth about $428,000. Finally, Mitsubishi UFJ Asset Management Co. Ltd. grew its holdings in HCA Healthcare by 5.7% during the 4th quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 196,319 shares of the company’s stock valued at $53,414,000 after purchasing an additional 10,506 shares during the last quarter. 62.73% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several equities analysts recently commented on HCA shares. StockNews.com upgraded shares of HCA Healthcare from a “buy” rating to a “strong-buy” rating in a report on Monday, July 1st. Oppenheimer upped their price target on shares of HCA Healthcare from $345.00 to $390.00 and gave the company an “outperform” rating in a report on Wednesday, July 24th. Leerink Partners upped their price target on shares of HCA Healthcare from $367.00 to $396.00 and gave the company an “outperform” rating in a report on Wednesday, July 24th. Baird R W raised shares of HCA Healthcare to a “strong-buy” rating in a research report on Thursday, May 30th. Finally, Cantor Fitzgerald reissued an “overweight” rating and issued a $392.00 price objective on shares of HCA Healthcare in a research report on Monday, August 19th. Five research analysts have rated the stock with a hold rating, fourteen have given a buy rating and three have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, HCA Healthcare has a consensus rating of “Moderate Buy” and an average target price of $359.89.

HCA Healthcare Trading Up 0.6 %

NYSE HCA opened at $388.65 on Thursday. The company has a quick ratio of 0.94, a current ratio of 1.06 and a debt-to-equity ratio of 27.11. The firm has a market cap of $101.79 billion, a PE ratio of 19.37, a price-to-earnings-growth ratio of 1.45 and a beta of 1.67. The company has a 50 day moving average price of $359.40 and a 200 day moving average price of $337.17. HCA Healthcare, Inc. has a 52 week low of $215.96 and a 52 week high of $403.05.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings data on Tuesday, July 23rd. The company reported $5.50 EPS for the quarter, topping the consensus estimate of $4.97 by $0.53. HCA Healthcare had a net margin of 8.40% and a return on equity of 553.13%. The firm had revenue of $17.49 billion during the quarter, compared to analyst estimates of $17.05 billion. During the same quarter in the previous year, the business posted $4.29 EPS. HCA Healthcare’s revenue was up 10.3% on a year-over-year basis. As a group, sell-side analysts forecast that HCA Healthcare, Inc. will post 22.48 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, September 30th. Shareholders of record on Monday, September 16th will be paid a dividend of $0.66 per share. The ex-dividend date of this dividend is Monday, September 16th. This represents a $2.64 dividend on an annualized basis and a yield of 0.68%. HCA Healthcare’s payout ratio is 13.16%.

Insider Buying and Selling at HCA Healthcare

In other news, SVP Kathryn A. Torres sold 1,857 shares of the stock in a transaction on Thursday, July 25th. The shares were sold at an average price of $355.05, for a total value of $659,327.85. Following the sale, the senior vice president now owns 17,755 shares in the company, valued at $6,303,912.75. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other HCA Healthcare news, SVP Kathleen M. Whalen sold 2,987 shares of the stock in a transaction dated Wednesday, July 31st. The stock was sold at an average price of $363.51, for a total transaction of $1,085,804.37. Following the sale, the senior vice president now directly owns 9,454 shares of the company’s stock, valued at approximately $3,436,623.54. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Kathryn A. Torres sold 1,857 shares of the stock in a transaction dated Thursday, July 25th. The stock was sold at an average price of $355.05, for a total value of $659,327.85. Following the sale, the senior vice president now directly owns 17,755 shares in the company, valued at $6,303,912.75. The disclosure for this sale can be found here. In the last quarter, insiders have sold 8,844 shares of company stock worth $3,185,932. 1.60% of the stock is owned by corporate insiders.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.